India Bromine Market Size, Share & Forecast, By Derivative, Application & End-Use Industry, 2026–2031

The India Bromine Market was valued at USD 137.8 million in 2025. This estimate covers elemental bromine sold into the domestic market and the bromine-equivalent value embedded in primary inorganic, organobromine and clear-brine-fluid products. The valuation was triangulated against producer capacities, trade flows and a blended realization of approximately USD 2,566 per bromine-equivalent tonne. The market is supported by pharmaceuticals, agrochemicals, electronics, flame retardants and oilfield applications, while Gujarat remains the principal domestic production hub.

The market is projected to grow at a CAGR of 6.90% during 2026–2031 and reach USD 205.8 million by 2031. Bromine-equivalent demand is modeled to rise to approximately 69.5 thousand tonnes, while product mix and realization contribute additional value growth. Higher-purity hydrogen bromide, custom organobromine intermediates, electronics-processing chemicals and application-specific inorganic bromides are expected to grow faster than conventional elemental bromine. The forecast assumes continued pharmaceutical and electronics expansion, stable access to Gujarat brine resources and no prolonged shutdown at a major production facility.

Profit pools are expected to move toward captive conversion and specialty derivatives. Elemental bromine remains essential, but its economics are more exposed to global prices, import parity and utilization. Pharmaceutical intermediates, electronic-grade hydrogen bromide, specialty flame-retardant formulations and regenerated bromide systems offer stronger differentiation through purity, process knowledge and customer qualification. Integrated producers can capture value at extraction, purification and conversion stages, while non-integrated processors remain more exposed to feedstock volatility. This shift makes research capability, audited quality systems and long-term offtake agreements increasingly important.

The principal risk is simultaneous exposure to concentrated imports and concentrated domestic production. India imported 8.69 thousand tonnes of elemental bromine in 2024, with Jordan and Israel providing more than 90% of volume. Domestic supply is centered on a small group of Gujarat producers whose output can be affected by plant reliability, weather, brine concentration and environmental compliance. A disruption can increase spot prices and constrain downstream plants that cannot readily switch grades. Buyers therefore require safety stock, diversified contracts and technical approval of multiple suppliers.

India ranked third by 2025 value in the selected peer set, behind China and Japan but ahead of South Korea and Saudi Arabia. India's USD 137.8 million market is smaller than China's USD 869.3 million and Japan's USD 194.4 million markets, but its 6.90% forecast CAGR compares favorably with Japan and South Korea. India also possesses an exportable production base: elemental-bromine exports reached USD 16.82 million in 2024, with China accounting for most outbound volume. This combination differentiates India from markets that depend predominantly on imported bromine products.

Pharmaceuticals provide the most resilient demand base, while electronics offers the strongest incremental opportunity. India's pharmaceutical exports reached USD 30.47 billion in FY 2024–25 and require a broad range of brominated intermediates and reagents. Electronics production reached ?11.3 lakh crore in the same fiscal year, expanding the addressable market for flame retardants and high-purity processing chemicals. Agrochemicals and oilfield fluids provide additional demand diversification but can be more cyclical. Suppliers serving regulated pharmaceutical and electronics customers generally face longer qualification cycles but gain stronger contract visibility.